Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
4DMedical Ltd ( (AU:4DX) ) just unveiled an update.
4DMedical Limited has issued 20,294 fully paid ordinary shares following the exercise of options under its Long Term Incentive Plan. This issuance was conducted without a disclosure to investors, in compliance with the Corporations Act, and a cleansing notice has been lodged with the ASX. The move aligns with regulatory requirements and reflects the company’s ongoing commitment to its incentive plans, potentially impacting its financial structure and stakeholder interests.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited operates within the healthcare industry, focusing on innovative medical imaging solutions. The company specializes in lung health diagnostics, providing advanced imaging technology to enhance the detection and management of respiratory conditions.
Average Trading Volume: 919,479
Technical Sentiment Signal: Sell
Current Market Cap: A$114.1M
See more data about 4DX stock on TipRanks’ Stock Analysis page.